267 related articles for article (PubMed ID: 24259265)
1. Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study.
Maihöfner CG; Heskamp ML
Eur J Pain; 2014 May; 18(5):671-9. PubMed ID: 24259265
[TBL] [Abstract][Full Text] [Related]
2. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Maihofner C; Heskamp ML
Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
[TBL] [Abstract][Full Text] [Related]
3. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C
Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
5. Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?
Kern KU; Nowack W; Poole C
Pain Pract; 2014 Feb; 14(2):E42-50. PubMed ID: 24289500
[TBL] [Abstract][Full Text] [Related]
6. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients.
Giménez-Milà M; Videla S; Navarro MA; Faulí A; Ojeda A; Bogdanovich A; Moreno LA; Hernández-Cera C; Busquets C
BMC Anesthesiol; 2014; 14():120. PubMed ID: 25580085
[TBL] [Abstract][Full Text] [Related]
8. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
Hansson P; Jensen TS; Kvarstein G; Strömberg M
Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
[TBL] [Abstract][Full Text] [Related]
9. High-concentration topical capsaicin in the management of refractory neuropathic pain in patients with neurofibromatosis type 1: a case series.
Bardo-Brouard P; Luizard C; Valeyrie-Allanore L; Goujon C; Do B; Colin A; Wolkenstein P; Paul M
Curr Med Res Opin; 2018 May; 34(5):887-891. PubMed ID: 29368950
[TBL] [Abstract][Full Text] [Related]
10. Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
Perrot S; Lantéri-Minet M
Eur J Pain; 2019 Jul; 23(6):1117-1128. PubMed ID: 30793414
[TBL] [Abstract][Full Text] [Related]
11. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
Wagner T; Poole C; Roth-Daniek A
Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
[TBL] [Abstract][Full Text] [Related]
12. QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.
Lantéri-Minet M; Perrot S
Curr Med Res Opin; 2019 Mar; 35(3):417-426. PubMed ID: 30550354
[TBL] [Abstract][Full Text] [Related]
13. Interest of a standardized hypnotic message for the reduction of pain and anxiety in cancer patients treated by capsaicin patch for neuropathic pain: a randomized controlled trial.
Etienne R; Laurent M; Henry A; Bioy A; Salleron J; Schohn CH; Cretineau N
BMC Complement Med Ther; 2021 May; 21(1):154. PubMed ID: 34044838
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study.
Zis P; Bernali N; Argira E; Siafaka I; Vadalouka A
Pain Physician; 2016; 19(7):E1049-53. PubMed ID: 27676676
[TBL] [Abstract][Full Text] [Related]
15. Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain.
Cruccu G; Nurmikko TJ; Ernault E; Riaz FK; McBride WT; Haanpää M
Eur J Pain; 2018 Apr; 22(4):700-706. PubMed ID: 29194851
[TBL] [Abstract][Full Text] [Related]
16. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Aitken E; McColl G; Kingsmore D
Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726
[TBL] [Abstract][Full Text] [Related]
17. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Goncalves D; Rebelo V; Barbosa P; Gomes A
Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
[TBL] [Abstract][Full Text] [Related]
18. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany.
Kern KU; Quandel T; Theis S; Schubert T
Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913
[TBL] [Abstract][Full Text] [Related]
20. High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment responders.
Höper J; Helfert S; Heskamp ML; Maihöfner CG; Baron R
Curr Med Res Opin; 2014 Apr; 30(4):565-74. PubMed ID: 24286590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
